CLINICAL_TRIALS ClinicalTrials.gov record update

A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05767021
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-06-12T00:05:56.041041+00:00
Published At: 2025-09-30T00:00:00+00:00
Record Updated At: 2026-06-10
Results Posted At: 2025-09-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Ulcerative Colitis", "Ulcerative Colitis Chronic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-06-10"
protocolSection.identificationModule.nctId: "NCT05767021"
protocolSection.identificationModule.officialTitle: "A Multicenter, Phase 3b, Open-Label, Single-Arm Study to Investigate Bowel Urgency and Its Relationship With Other Outcome Measures in Adults With Moderately to Severely Active Ulcerative Colitis Treated With Mirikizumab"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-09-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.